Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript

VRTX earnings call for the period ending September 30, 2024.…

Vertex Pharmaceuticals Incorporated 2024 Q3 - Results - Earnings Call Presentation

…

Vertex Pharmaceuticals: Kursziel gesenkt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten der Oppenheimer senken das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits @themotleyfool #stocks $VRTX

Its latest report of clinical data suggests it has a winner on its hands.…

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits

Its latest report of clinical data suggests it has a winner on its hands.…

Vertex Pharmaceuticals: A Long-Term Growth Monster

…

Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride

…

Vertex Pharmaceuticals Aktie: Wachstum durch CF-Franchise und Pipeline-Potenzial!

Charlotte (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BofA Securities: Rating und Kursziel BofA-Analyst Geoff Meacham hat das Kursziel für Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals Aktie: Phase 2 Ergebnisse zu Suzetrigine entscheidend

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Rating und Kursziel RBC Capital Markets hat das Kursziel für die Aktie von…

Vertex Pharmaceuticals Aktie: Fair bewertet?

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Morgan Stanley: 1. Anpassung des Kursziels und Bewertung - Morgan Stanley hat das Kursziel für…

The Best Biotech Stock to Invest $1,000 in Right Now

Vertex Pharmaceuticals isnt an ordinary biotech stock.…

The Best Biotech Stock to Invest $1,000 in Right Now

Vertex Pharmaceuticals isnt an ordinary biotech stock.…

The Best Biotech Stock to Invest $1,000 in Right Now @themotleyfool #stocks $VRTX

Vertex Pharmaceuticals isnt an ordinary biotech stock.…

Vertex Pharmaceuticals, Inc. (VRTX) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)

…

Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? Im Not Convinced

…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX

Vertex should have a future full of bright tomorrows.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex should have a future full of bright tomorrows.…

Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead

Vertex Pharmaceuticals has a lot going for it.…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Is It Too Late to Buy Vertex Pharmaceuticals Stock? @themotleyfool #stocks $VRTX $MRK $PFE $CRSP

Shares of the rare disease drugmaker are already up more than 40% over the past year.…

Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Shares of the rare disease drugmaker are already up more than 40% over the past year.…

Vertex Pharmaceuticals: Umsatzprognose angehoben - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Oppenheimer: Oppenheimer hebt in einer aktuellen Aktienanalyse das Kursziel für die Aktie von Vertex…

Vertex Pharmaceuticals: Gute Logik - Aktienanalyse

Charlotte, NC (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Truist: Joon Lee, Analyst von Truist, stuft in einer aktuellen Aktienanalyse die Aktie von…

Vertex Pharmaceuticals: Abstufung wegen Bewertung, neues Kursziel - Aktienanalyse

London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays: Barclays stuft in einer aktuellen Aktienanalyse die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Vertex Pharmaceuticals: Kursziel um 100 USD angepasst

New York (www.aktiencheck.de) - Rating-Update: Andrew Fein, Analyst von H.C. Wainwright & Co, empfiehlt die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2024.…

Vertex Pharmaceuticals: Kursziel angehoben

Vancouver (www.aktiencheck.de) - Rating-Update: Die Analysten von Canaccord Genuity bewerten die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…

Vertex Pharmaceuticals: Kursziel vor Q2-Zahlen angehoben - Aktienanalyse

San Francisco (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Citizens JMP Securities: Die Analysten von Citizens JMP Securities heben in einer aktuellen Aktienanalyse…

Is Vertex Pharmaceuticals Monopoly in Danger?

As a shareholder, I am nowhere close to panic mode.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX

Vertex shares have soared by triple-digit percentages over the past three years.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex shares have soared by triple-digit percentages over the past three years.…

Vertex Pharmaceuticals: Günstiges Chance/Risiko-Verhältnis - Aktienanalyse

Milwaukee (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Robert W. Baird: Die Analysten von Robert W. Baird nehmen die Coverage der Aktie von…

Vertex Pharmaceuticals: Alpine-Übernahme im Fokus - Kursziel auf 500 USD erhöht - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von H.C. Wainwright & Co.: Die Analysten von H.C. Wainwright & Co. stufen die Aktie…

Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock By Investing.com

Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock…

Did Vertex Pharmaceuticals Just Invent the Next Ozempic?

Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.…

Vertex Pharmaceuticals: Coverage aufgenommen

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Redburn Atlantic nehmen die Coverage der Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to…

Vertex Pharmaceuticals: Neues Kursziel

San Francisco (www.aktiencheck.de) - Rating-Update: Die Analysten von Wells Fargo Advisors stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Vertex Pharmaceuticals: Fortschritte in der Pipeline, M&A-Aktivitäten und finanzielle Stärke im Fokus - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Argus Research: Jasper Hellweg, Analyst von Argus Research, erhöht in einer aktuellen Aktienanalyse sein…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Cystic Fibrosis Therapeutics Global Strategic Business Report 2023-2030 Featuring Key Players - AbbVie, Galapagos, Genentech, Gilead Sciences, Novartis, and Vertex Pharmaceuticals

Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has…

dpa-AFX ProFeed